Request Appointment
161 Fort Washington AveNew York, NY 10032
Fax+1 212-305-6891
Overview of Dr. Chakraborty
Dr. Rajshekhar Chakraborty is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Arkansas for Medical Sciences (UAMS) College of Medicine and has been in practice 9 years. He is one of 121 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 372 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2017 - 2020
University of Arkansas For Medical Sciences College of MedicineClass of 2010- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology
Certifications & Licensure
NY State Medical License 2020 - 2025
OH State Medical License 2017 - 2021
MN State Medical License 2014 - 2017
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma.Meera Mohan, Aniko Szabo, Heloise Cheruvalath, Anna Clennon, Vineel Bhatlapenumarthi
Blood Cancer Journal. 2025-04-23 - The Impact of Melphalan Conditioning and CD34Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis.Eli Muchtar, Vaishali Sanchorawala, Hamza Hassan, Ute Hegenbart, Stefan Schönland
American Journal of Hematology. 2025-04-11 - Real-world treatment patterns for teclistamab and talquetamab in multiple myeloma (MM): experience from 609 patients.Farheen Chunara, Chris Lugo, Kristen Osinski, Mansi R Shah, Nishi Shah
Blood Cancer Journal. 2025-04-08
Abstracts/Posters
- Risk of Serious Infections with Carfilzomib in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsRajshekhar Chakraborty, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Venous thromboembolism risk with contemporary lenalidomide-based regimes for multiple myeloma: A systematic review and meta-analysis.ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
